Covered recipient · General Payments record
DINESH EDEM
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$811.19
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $493.21 | 20 |
| Education | $96.81 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $227.69 | 8 |
| Corcept Therapeutics | $105.89 | 6 |
| Xeris Pharmaceuticals, Inc. | $102.16 | 2 |
| Lilly USA, LLC | $37.10 | 2 |
| Averitas Pharma Inc. | $31.05 | 1 |
| Kyowa Kirin, Inc. | $27.58 | 1 |
| Neurocrine BioSciences, Inc. | $25.37 | 1 |
| DEXCOM, INC. | $19.05 | 1 |
| CeQur Corporation | $14.13 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Averitas Pharma Inc. | $31.05 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133424411 | CMS |
| CeQur Corporation | $14.13 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126844426 | CMS |
| Corcept Therapeutics | $15.75 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117754340 | CMS |
| Corcept Therapeutics | $14.71 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117754410 | CMS |
| Corcept Therapeutics | $15.71 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117754422 | CMS |
| Corcept Therapeutics | $19.30 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117754436 | CMS |
| Corcept Therapeutics | $21.96 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117754472 | CMS |
| Corcept Therapeutics | $18.46 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117754474 | CMS |
| Dexcom, Inc. | $19.05 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153296668 | CMS |
| Kyowa Kirin, Inc. | $27.58 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127028887 | CMS |
| Lilly USA, LLC | $19.21 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136142734 | CMS |
| Lilly USA, LLC | $17.89 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136158847 | CMS |
| Neurocrine Biosciences, Inc. | $25.37 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150838862 | CMS |
| Novo Nordisk Inc | $12.15 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096929558 | CMS |
| Novo Nordisk Inc | $52.02 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096636171 | CMS |
| Novo Nordisk Inc | $32.27 | 08/23/2024 | Education | Undisputed | 01/23/2026 | 1097510708 | CMS |
| Novo Nordisk Inc | $32.27 | 08/23/2024 | Education | Undisputed | 01/23/2026 | 1097547048 | CMS |
| Novo Nordisk Inc | $32.27 | 08/23/2024 | Education | Undisputed | 01/23/2026 | 1097668112 | CMS |
| Novo Nordisk Inc | $50.57 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096630143 | CMS |
| Novo Nordisk Inc | $4.74 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096867739 | CMS |
| Novo Nordisk Inc | $11.40 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097698567 | CMS |
| Xeris Pharmaceuticals, Inc. | $17.62 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144592834 | CMS |
| Xeris Pharmaceuticals, Inc. | $84.54 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144592836 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.